TaskUs, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data TaskUs, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	360	478	761	960	924	995	1,184
Cost of revenue	195	271	432	559	539	603	736
Gross profit	165	208	329	402	386	392	447
Selling, general and administrative	90.6	114	335	260	229	240	245
Operating income	36.9	50.3	-54.3	83.9	95	92.4	141
Interest expense	9.35	7.48	6.5	11.9	21.7	21.5	18.4
Interest income				0.1	1.6	5.5	5.8
Other non-operating income	2.01	1.57	-0.18	-7.44	1.71	3.31	14.4
Pre-tax income	29.5	44.4	-61	64.5	75	74.2	137
Income tax	-4.41	9.89	-2.27	24.1	29.3	28.3	34.4
Net income	33.9	34.5	-58.7	40.4	45.7	45.9	102
EBITDA	53.2	70.5	-25.2	122	135	133	182
EPS, basic	0.37	0.38	-0.62	0.41	0.49	0.52	1.14
EPS, diluted	0.37	0.38	-0.62	0.39	0.48	0.50	1.10
Shares, basic (weighted)	91.7	91.7	94.8	97.8	93.9	88.9	90
Shares, diluted (weighted)	91.7	91.7	94.8	103	96.2	92.3	93
Dividend per share	1.47		0.55

Balance sheet

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	37.5	108	63.6	134	126	192	212
Receivables		87.8	163	179	177	199	254
Other current assets		1.05	4.43	5.5	23.9	43.3	43
Total current assets		211	246	341	329	435	509
Property, plant and equipment		57	80	75.1	68.9	66.8	95.4
Lease right-of-use assets			0	41.5	44.3	47.3	53.2
Goodwill		196	196	217	218	217	220
Intangible assets		240	221	213	193	173	153
Other non-current assets		2.63	5.02	7.49	6.54	6.09	7.54
Total assets		708	750	902	864	953	1,051
Accounts payable		41.9	40.9	37.1	26.1	53.4	45.2
Accrued liabilities		22	36.7	48.7	40.3	54.2	64.5
Deferred revenue		4.71	4.1	3.48	4.08	3.73	3.27
Short-term debt		46	51.1	3.33	8.06	14.8	21.6
Total current liabilities		115	136	110	102	152	163
Long-term debt		199	187	264	256	241	220
Lease liabilities			0	32.4	31.5	32.9	37.1
Other non-current liabilities			0	0.29	0.23	0.08	0
Total liabilities		372	371	446	423	456	451
Total debt		245	238	268	264	256	241
Paid-in capital		398	556	632	683	727	755
Retained earnings		-67.4	-176	-136	-90	-44.1	58.2
Treasury stock			0	-31	-144	-162	-189
Other comprehensive income		3.42	-2.16	-10.6	-9.55	-25.4	-24.7
Shareholders' equity	298	335	379	456	441	497	600
Total equity	298	335	379	456	441	497	600
Total liabilities and equity		708	750	902	864	953	1,051

Cash flow statement

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	33.9	34.5	-58.7	40.4	45.7	45.9	102
Depreciation and amortization	16.3	20.1	29	37.9	40.4	40.2	41.5
Stock-based compensation	0	0	46.2	69	52.8	41.8	29.7
Deferred income tax	-8.84	-7.02	-11.5	-11.8	-7.96	-10.9	-7.47
Change in receivables	-13	-32	-76.2	-15.1	1.86	-22.8	-55.1
Change in payables	-2.06	13.5	4.49	1.82	-9.83	23.5	-12.8
Cash from operations	43.8	58.9	-32.7	147	144	139	137
Capital expenditures	-20	-28.9	-59.4	-43.8	-31	-39.1	-63.5
Acquisitions		0	0	-23.2	0	0
Cash from investing	-20	-28.9	-59.4	-68	-32	-39.1	-63.5
Debt repaid	-0.95	-2.89	-6.56	-273	-3.71	-8.44	-15.2
Stock issued	0	0	121	0	0
Share buybacks		0	0	-31	-112	-18.6	-27.8
Dividends paid	-135	0	-50	0	0
Cash from financing	-12.8	37	54.4	-4.04	-119	-25.2	-44.2
Exchange rate effect	1.33	3.21	-6.5	-4.66	-0.81	-8.22	-9.99
Net change in cash	10.9	67	-37.6	75.1	-7.41	74.6	29.5
Free cash flow	23.7	30	-92	103	113	99.8	73.7
Interest paid	6.82	6.96	5.91	9.95	21.6	21.1	17.8
Income taxes paid	8	15.5	7.49	31.8	31.7	34.2	35.7

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $8.20 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	36.1%	Gross profit / revenue.
Operating margin	11.7%	Operating income / revenue.
EBITDA margin	15.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	11.9%	Pre-tax income / revenue.
Net margin	8.8%	Net income / revenue.
FCF margin	9.8%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	14.1%	Cash from operations / revenue.
Effective tax rate	26.3%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	35.8%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	10.8%	Net income / average total assets.
Return on invested capital (ROIC)	17.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	18.9%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.9%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	4.3%	Capital expenditures / revenue.
D&A / revenue	3.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	19.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	7.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	19.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	14.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	3.6%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	16.6%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	52.2%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	18.8%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	22.8%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	37.3%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	14.4%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	20.9%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	123.0%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	36.3%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	24.3%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	120.0%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	41.3%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	23.7%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-1.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-2.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	18.4%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-26.1%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-10.6%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	19.7%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	20.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	9.6%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	12.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	10.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	5.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	8.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.8%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-3.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.95x	Current assets / current liabilities.
Quick ratio	2.63x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.12x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.64x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	49.3%	Total debt / total assets.
Liabilities / assets	69.9%	Total liabilities / total assets.
Net debt	$311.7M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	1.66x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	6.19x	Operating income / interest expense.
Working capital	$314.6M	Current assets - current liabilities.
Goodwill and intangibles / assets	36.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$62.3M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.23x	Revenue / average total assets.
Fixed asset turnover	14.3x	Revenue / average property, plant and equipment.
Receivables turnover	5.00x	Revenue / average receivables.
Days sales outstanding	73 days	365 x average receivables / revenue.
Days payables	17 days	365 x average accounts payable / cost of revenue.
FCF conversion	112.3%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	30.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.16	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$13.26	Revenue / diluted weighted shares.
FCF per share	$1.30	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.87	Cash from operations / diluted weighted shares.
Book value per share	$3.24	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$0.67	Tangible book value / shares outstanding.
Cash per share	$1.95	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	0.0%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$751.8M	Share price x shares outstanding.
Enterprise value	$1.06B	Market cap + total debt - cash - short-term investments.
P/E	7.00x	Market cap / net income. Only when net income is positive.
P/S	0.61x	Market cap / revenue.
P/B	2.51x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	6.23x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	4.34x	Market cap / cash from operations, when positive.
EV/Sales	0.87x	Enterprise value / revenue.
EV/EBIT	7.41x	Enterprise value / operating income, when both are positive.
EV/EBITDA	5.66x	Enterprise value / EBITDA, when both are positive.
EV/FCF	8.82x	Enterprise value / free cash flow, when both are positive.
FCF yield	16.0%	Free cash flow / market cap.
Earnings yield	14.3%	Net income / market cap (the inverse of P/E).
Shareholder yield	0.0%	(Dividends paid + share buybacks) / market cap.
PEG	0.17x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was TaskUs, Inc.'s revenue in fiscal 2025?

TaskUs, Inc. reported revenue of $1.18B for fiscal 2025, 19% higher than the year before.

Was TaskUs, Inc. profitable in fiscal 2025?

Yes. Net income was $102.3M, a net margin of 8.6%.

How much free cash flow did TaskUs, Inc. generate in fiscal 2025?

Cash from operations of $137.2M minus capital expenditures of $63.5M left free cash flow of $73.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to TaskUs, Inc.